Etravirine-raltegravir, a marked interaction in HIV-1-infected patients: about four cases.
Ménard
Amélie
A
Solas
Caroline
C
Mokthari
Saadia
S
Bregigeon
Sylvie
S
Drogoul
Marie-Pierre
MP
Tamalet
Catherine
C
Lacarelle
Bruno
B
Martin
Isabelle Poizot
IP
D019380:Anti-HIV Agents / Q000008:administration & dosage*; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D015497:HIV-1; D006801:Humans; D009570:Nitriles; D011724:Pyridazines / Q000008:administration & dosage*; D011743:Pyrimidines; D011760:Pyrrolidinones / Q000008:administration & dosage*; D000068898:Raltegravir Potassium; D019562:Viral Load
D019380:Anti-HIV Agents; D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D011760:Pyrrolidinones; C451734:etravirine; D000068898:Raltegravir Potassium